Alfa Laval strengthens Flemingsberg – establishes itself in a growing city of the future

In May 2025, Alfa Laval moved into its new office and innovation center, spanning approximately 20,000 square meters, together with around 700 employees. At the same time, the restaurant K-märkt opened, further expanding the range of services available in Flemingsberg. The Royal Swedish Opera and Dramaten, Alfa Laval, Restaurant Billmans, and K-märkt all represent important pieces of the puzzle in the development of Flemingsberg.

It’s a warm May day when 700 Alfa Laval employees are welcomed to Flemingsberg with signs, balloons, and friendly faces guiding them to their new office. This will be their new workplace, located at the heart of one of Sweden’s largest urban development projects, with the ambitious goal of reaching 50,000 workers, 50,000 residents, and 50,000 visitors in Flemingsberg by 2050.

“We are very pleased to have established our new premises in Flemingsberg. This expansion represents a significant improvement for our employees, our operations, and our customers. Flemingsberg is now Alfa Laval’s hub for all development of separators within the marine, energy, food, and pharma sectors. We are also establishing our Innovation Centre for pharma here, further reinforcing our commitment to innovation and growth.”
– Peter Nielsen, Alfa Laval’s Site Manager for Flemingsberg and President of the Business Unit High Speed Separators

“We are very happy to welcome Alfa Laval to Flemingsberg and as a tenant of Fabege. Their presence strengthens the area’s position as a dynamic and innovative hub for research and development. We look forward to a continued successful collaboration that contributes to Flemingsberg’s ongoing growth and success.”
– Anna Nyberg, Head of Business Development at Fabege

Flemingsberg is not just a place you pass – it’s a place on the move.
Welcome to join us, too!

Published On: 3 December 2025
  • Inhalation Sciences Sweden

    In Flemingsberg, we have access to the advanced labs that we need, and it offers the right facilities we need to expand.

  • Mando Group

    Our research and development has been conducted in co-operation with both KI and Karolinska University Hospital here in Flemingsberg. The positive climate on Campus Flemingsberg encourages original ideas and co-operation.

  • NextCell Pharma

    Flemingsberg is entirely the right place for us due to its closeness to co-operation partners and the clinical research at Karolinska University Hospital.

  • Sprint Bioscience

    Flemingsberg offers us the opportunity to grow and provides a good working environment for our employees. Other advantages are the proximity to research at Karolinska Institutet and the clinical research at Karolinska University Hospita